glp-1 study Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 weight loss drugs leave
Description
Kotagal V, Albin RL, Mller ML, Koeppe RA, Frey KA, Bohnen NI
The FDA issued a February 2026 statement that it "intends to take action against non-FDA-approved GLP-1 drugs." As brand-name supply stabilizes, the legal justification for mass-compounding (which requires a drug shortage) weakens
How else can Walgreens support patients on their weight loss journey
When these effects work alongside insulin therapy, many patients see improvements in their overall glucose patterns
Patients can also get metabolic testing and personalized guidance from licensed healthcare providers who specialize in obesity and related conditions
State leaders say soaring costs forced the change, especially as Medicaid faces mounting funding pressure under the Trump administration
